CB
LIVE

Serial Number

79275433

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CB Trademark

Serial Number: 79275433 • Registration: 6110252

CB is a trademark filed by NOVARTIS AG on November 18, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 18, 2019

Registration Date

July 28, 2020

Published for Opposition

May 12, 2020

Goods & Services

[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system [ ; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Feb 12, 2026 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Feb 12, 2026 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 9, 2026 APRE
TEAS SECTION 71 & 15 RECEIVED
Oct 6, 2025 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 28, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 6, 2020 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Nov 17, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 17, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 28, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 28, 2020 R.PR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 28, 2020 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
May 15, 2020 CRCV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2020 CNSA
REFUSAL PROCESSED BY IB
Mar 21, 2020 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 9, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 9, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 9, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 9, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 9, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 9, 2020 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 3, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 3, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 8, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 7, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 14, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 2, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 2, 2020 REPR